Cancer remains one of the leading causes of death worldwide, prompting extensive research into novel theranostic (combined word of diagnostic and therapeutic) strategies. Nanomedicine has emerged as a potential breakthrough in cancer theranosis, overcoming limitations of conventional approaches. Among such approaches, carbon dots (CDs) with a size smaller than 10 nm have garnered significant attention for their potential use in cancer theranosis, owing to their low toxicity, good water solubility, easy synthesis, facile surface modification, and unique optical and photothermal and photodynamic properties. Researchers have demonstrated that surface functionalization of CDs with diverse hydrophilic groups can be easily achieved by choosing proper carbon precursors in synthesis, and further surface modification of CDs with cancer-targeting ligands, photosensitizers, anticancer drugs, and genes can also be easily achieved using various methods, thereby establishing a versatile approach for cancer theranosis. This review described the various surface modification methods of CDs, in vitro and in vivo toxicity of CDs, and various cancer theranostic methods such as drug delivery, photodynamic therapy, photothermal therapy, gene therapy, sonodynamic therapy, and gas therapy. Therefore, CDs can serve as various mono and combined theranostic modalities, offering us new methods for cancer theranosis.
Nuclear magnetic resonance (NMR) spectroscopy provides detailed information about dynamic processes through line-shape changes, which are traditionally limited to equilibrium conditions. However, a wealth of information is available by studying chemical reactions under off-equilibrium conditions—e.g., in states that arise upon mixing reactants that subsequently undergo chemical changes—and in monitoring the reactants and products in real time. Herein, we propose and demonstrate a time-resolved kinetic NMR experiment that combines rapid mixing techniques, continuous flow, and single-scan spectroscopic imaging methods, leading in unison to a 2D spectrotemporal NMR correlation that provides high-quality kinetic information of off-equilibrium chemical reactions. These kinetic 2D NMR spectra possess a high-resolution spectral dimension revealing the individual chemical sites, correlated with a time-independent, steady-state spatial axis that delivers information concerning temporal changes along the reaction coordinate. A comprehensive description of the kinetic, spectroscopic, and experimental features associated with these spectrotemporal NMR analyses is presented. Experimental demonstrations are carried out using an enzymatically catalyzed reaction leading to site- and time-resolved kinetic NMR data, that are in excellent agreement with control experiments and literature values.
Although numerous studies have investigated gadolinium oxide (Gd2O3) nanoparticles (NPs) as positive (T1) magnetic resonance imaging (MRI) contrast agents (CAs), comprehensive reviews on this topic remain scarce. Therefore, it is essential to evaluate their current status and outline prospects. Despite promising physicochemical properties such as considerably higher relaxivities compared to 3–5 s−1mM−1 of clinically approved Gd(III)-chelate contrast agents and encouraging results from in vivo animal studies such as highly improved contrast enhancements, drug loading, and tumor targeting, extensive in vivo toxicity assessments including long-term toxicity and formulation advancements suitable for renal excretion (d < ~3 nm) are still required for clinical translation. This review summarizes the synthesis, characterization, in vitro and in vivo toxicity, and in vivo MRI applications of surface-modified Gd2O3 NPs as T1 MRI CAs. Finally, future perspectives on the development of surface-modified Gd2O3 NPs as potential next-generation T1 MRI CAs are discussed.
In recent years, significant advances in enhancing the quantum yield (QY) of trivalent lanthanide (Ln3+) ion-based nanoparticles have been achieved through photosensitization, using host matrices or capping organic ligands as photosensitizers to absorb incoming photons and transfer energy to the Ln3+ ions. The Ln3+ ion-based nanoparticles possess several excellent fluorescent properties, such as nearly constant transition energies, atomic-like sharp transitions, long emission lifetimes, large Stokes shifts, high photostability, and resistance to photobleaching; these properties make them more promising candidates as next-generation fluorescence probes in the visible region, compared with other traditional materials such as organic dyes and quantum dots. However, their QYs are generally low and thus need to be improved to facilitate and extend their applications. Considerable efforts have been made to improve the QYs of Ln3+ ion-based nanoparticles through photosensitization. These efforts include the doping of Ln3+ ions into host matrices or capping the nanoparticles with organic ligands. Among the Ln3+ ion-based nanoparticles investigated in previous studies, this review focuses on those containing Eu3+, Tb3+, and Dy3+ ions with red, green, and yellow emission colors, respectively. The emission intensities of Eu3+ and Tb3+ ions are stronger than those of other Ln3+ ions; therefore, the majority of the reported studies focused on Eu3+ and Tb3+ ion-based nanoparticles. This review discusses the principles of photosensitization, several examples of photosensitized Ln3+ ion-based nanoparticles, and in vitro and in vivo biomedical fluorescent imaging (FI) applications. This information provides valuable insight into the development of Ln3+ ion-based nanoparticles with high QYs through photosensitization, with future potential applications in biomedical FI.
Carbon dots (CDs) are metal-free carbon-based nanoparticles. They possess excellent photoluminescent properties, various physical properties, good chemical stability, high water solubility, high biocompatibility, and tunable surface functionalities, suitable for biomedical applications. Their properties are subject to synthetic conditions such as pH, reaction time, temperature, precursor, and solvent. Until now, a large number of articles on the synthesis and biomedical applications of CDs using their photoluminescent properties have been reported. However, their research on magnetic properties and especially, diamagnetic chemical exchange saturation transfer (diaCEST) in magnetic resonance imaging (MRI) is very poor. The diaCEST MRI contrast agents are based on exchangeable protons of materials with bulk water protons and thus, different from conventional MRI contrast agents, which are based on enhancements of proton spin relaxations of bulk water and tissue. In this review, various syntheses, characterizations, magnetic properties, and potential applications of CDs as diaCEST MRI contrast agents are reviewed. Finally, future perspectives of CDs as the next-generation diaCEST MRI contrast agents are discussed.